ProKidney
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ProKidney and other ETFs, options, and stocks.About PROK
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD.
CEOBruce Culleton
CEOBruce Culleton
Employees204
Employees204
HeadquartersWinston-Salem, North Carolina
HeadquartersWinston-Salem, North Carolina
Founded2015
Founded2015
Employees204
Employees204
PROK Key Statistics
Market cap287.03M
Market cap287.03M
Price-Earnings ratio-1.64
Price-Earnings ratio-1.64
Dividend yield—
Dividend yield—
Average volume521.70K
Average volume521.70K
High today$1.01
High today$1.01
Low today$0.95
Low today$0.95
Open price$0.9846
Open price$0.9846
Volume42.21K
Volume42.21K
52 Week high$3.00
52 Week high$3.00
52 Week low$0.4603
52 Week low$0.4603
People also own
Based on the portfolios of people who own PROK. This list is generated using Robinhood data, and it’s not a recommendation.